Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)

NCT02194231

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Azienda ospedaliera ss. Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy
  • Cliniche Humanitas Gavazzeni Bergamo, BG, Italy
  • Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi Bologna, Bo, Italy
  • P.O. Spedalli Civili Brescia, BS, Italy
View Trial Details
Completed

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

NCT02272413

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • Lalita Pandit, M.D., Inc. Fountain Valley, California, United States
  • Southern California Oncology Research Alliance Los Angeles, California, United States
View all 189 locations
View Trial Details
Completed

A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT02031458

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • HonorHealth Research Institute - Bisgrove Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Angeles Clinic & Rsch Inst Los Angeles, California, United States
View all 110 locations
View Trial Details
Completed

Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery

NCT00290355

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Edegem, Belgium
  • GSK Investigational Site Ghent, Belgium
  • GSK Investigational Site Leuven, Belgium
View all 62 locations
View Trial Details
Completed

OSI-774 (Erlotinib, Tarceva) in Elderly Patients

NCT00200395

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beth Israel Medical Center New York, United States
  • New York University New York, United States
  • Albert Einstein Cancer Center The Bronx, New York, United States
  • Montefiore Medical Center- The Bronx, New York, United States
View Trial Details
Completed

Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC

NCT02047344

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • UCSF San Francisco, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • John Hopkins University Baltimore, Maryland, United States
View Trial Details

Related conditions